CIK 0001787400
- Non-accelerated filer
- Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474515206
- Phone
- +1 925-407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-14 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +3,333,333 | $18.00 | $60.0M | 5,605,129 |
| 2020-07-14 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Conversion · Series B Preferred Stock | −8,405,656 | 0 | ||
| 2020-07-14 | Flynn James E 10% owner | Conversion | +709,936 | 709,936 | ||
| 2020-07-14 | Flynn James E 10% owner | Conversion | +709,936 | 709,936 | ||
| 2020-07-14 | Flynn James E 10% owner | Purchase | +500,000 | $18.00 | $9.0M | 1,209,936 |
| 2020-07-14 | Flynn James E 10% owner | Purchase | +500,000 | $18.00 | $9.0M | 1,209,936 |
| 2020-07-14 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −2,626,767 | 0 | ||
| 2020-07-14 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −2,626,767 | 0 | ||
| 2020-07-09 | Behbahani Ali Director | Grant or award · Stock Option (right to buy) | +10,700 | 10,700 | ||
| 2020-07-09 | George Simeon Director | Grant or award · Stock Option (right to buy) | +10,700 | 10,700 | ||
| 2020-07-09 | Trager James Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +82,400 | 82,400 | ||
| 2020-07-09 | Trager James Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +31,100 | 31,100 | ||
| 2020-07-09 | Plunkett Matthew Chief Financial Officer | Grant or award · Stock Option (right to buy) | +77,800 | 77,800 | ||
| 2020-07-09 | Azzam Fouad Oscar Director | Grant or award · Stock Option (right to buy) | +10,700 | 10,700 | ||
| 2020-07-09 | Mahmood Nadir Chief Business Officer | Grant or award · Stock Option (right to buy) | +48,400 | 48,400 | ||
| 2020-07-09 | Mahmood Nadir Chief Business Officer | Grant or award · Stock Option (right to buy) | +27,600 | 27,600 | ||
| 2020-07-09 | Dybbs Michael Director | Grant or award · Stock Option (right to buy) | +10,700 | 10,700 | ||
| 2020-07-09 | Scheiner Zachary Director | Grant or award · Stock Option (right to buy) | +10,700 | 10,700 | ||
| 2020-07-09 | Rajangam Kanya Chief Medical Officer | Grant or award · Stock Option (right to buy) | +70,600 | 70,600 | ||
| 2020-07-09 | Shawver Laura Director | Grant or award · Stock Option (right to buy) | +10,700 | 10,700 |
Page 18 of 19 · 364 trades